This publication on Age-Related Macular Degeneration (AMD), compiles the whole concept of macular degeneration from its initial evaluation to the most revolutionary treatments performed today. Nowadays, AMD is considered the most common cause of blindness in developed nations. Approximately 10-15% of patients over the age of 65 have signs of AMD and by the age of 70 the number increases to 31%. It is important to understand that as our society ages, the prevalence of AMD would increase causing a tremendous impact on their quality of life. Each one of the Contributing Authors in this Volume attest to a significant progress and achievements in this field, as we continue to improve our diagnosis and management of this devastating disease. We have been fortunate by the participation of these prestigious authorities who have provided us with most valuable information, perspectives and insights. May ""THE HIGHLIGHTS COLLECTION"" on Age-Related Macular Degeneration contribute to your further understanding of what is best for your patients, and to master the ""state of the art"" techniques on this field. The topics are: Normal Anatomy of the Macula; Screening of Macular Function; Pathology of Age-Related Macular Degeneration; Risk Factors Associated with Age-Related Macular Degeneration (AMD); Age-Related Macular Degeneration Symptoms, Signs and Diagnostic Methods; Diagnosis of Age-Related Macular Degeneration; Choroidal Neovascularization in the Presence of Age-related Macular Degeneration (AMD); Current and Future Treatments in Age Related Macular Degeneration; Photodynamic Therapy; Anti-angiogenic Treatments for Exudative AMD; Clinical Trials in Age-Related Macular Degeneration; Vision Rehabilitation; The Role of Nutrition in the Prevention of ARMD